You are here: Industry Insights > PAD

News List

12-Month Below-the-Knee Data with MedAlliance's SELUTION SLR™ Presented as Late Breaking Trial at LINC europeanpharmaceuticalreview
January 29, 2021
12-month results from the PRESTIGE* Below-the-Knee (BTK) study have been presented as a Late Breaking Trial at LINC 2021.
MC2 Therapeutics Announces Positive Top-line Results from EU Phase 3 Head-to-Head Trial Comparing Wynzora™ Cream to Daivobet® Gel in Patients with Psoriasis b3cnewswire
December 25, 2019
MC2 Therapeutics, an emerging pharmaceutical company focused on novel PAD™ Technology based topical therapies for chronic inflammatory conditionss, announced that its EU Phase 3 trial (n=490) on the company’s investigational drug ...
Poor Circulation in Legs? Statin Meds Can Keep You Living Longer drugs
September 05, 2019
Folks with peripheral artery disease (PAD) have a much lower risk of death if they take cholesterol-lowering statins as directed by their doctor, a new study reports.
Smoking Creates Long-Lasting Risk for Clogged Leg Arteries drugs
August 06, 2019
Cigarette smokers have a sharply higher risk of peripheral artery disease (PAD) -- and even if they quit, that added risk can last for decades, a new study warns.
Online Symptom Self-Management + Telehealth Aids Pain, Mood drugs
July 29, 2019
Online symptom self-management plus clinician telecare can be effective for individuals with pain, depression, and anxiety...
FDA Issues Update on Mortality Risk With Paclitaxel-Coated Products drugs
March 19, 2019
A preliminary analysis has revealed a "potentially concerning signal" of increased long-term mortality risk with paclitaxel-coated products indicated for peripheral arterial disease (PAD), according to a March 15 update from the U.S. Food and Drug Admini